Well, the ASCO abstract drop has certainly brought with it some good, bad, and even confusing data to explore this year, perhaps not helped by some of the weird assumptions and misconceptions being bandied around.

In our latest preview, we take another dozen or so key topics and explore what we know and don’t know in the context of the broader landscape. We also address some of the inaccuracies out there for the unwary.

There’s a lot to learn here and the devil, as always, is in the details.

“There’s just a song in all the trouble and the strife
You do the walk, yeah, you do the walk of life
You do the walk of life.”

So grab a cup of coffee and take a walk through the minefield of initial data with us… after all, not all of it is in dire straits 😉

To learn more and get a heads up on our latest oncology insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by